Rep. Julie Johnson Sells Cigna Group (NYSE:CI) Shares

Representative Julie Johnson (D-Texas) recently sold shares of Cigna Group (NYSE:CI). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Cigna Group stock on November 13th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

  • Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of Xcel Energy (NASDAQ:XEL) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of Wells Fargo & Company (NYSE:WFC) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 11/13/2025.
  • Sold $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 11/13/2025.

Cigna Group Price Performance

CI opened at $274.70 on Monday. The company has a 50 day moving average of $280.44 and a two-hundred day moving average of $293.90. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a market cap of $73.38 billion, a P/E ratio of 12.12, a P/E/G ratio of 1.00 and a beta of 0.25.

Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s payout ratio is currently 26.64%.

Wall Street Analyst Weigh In

A number of research analysts have commented on CI shares. Sanford C. Bernstein reduced their target price on Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a report on Wednesday, November 12th. Guggenheim reissued a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research report on Tuesday, December 2nd. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, December 8th. Finally, Zacks Research downgraded shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $331.77.

View Our Latest Analysis on Cigna Group

Institutional Investors Weigh In On Cigna Group

A number of hedge funds have recently added to or reduced their stakes in CI. Harbor Capital Advisors Inc. grew its position in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the last quarter. Flaharty Asset Management LLC acquired a new position in shares of Cigna Group during the first quarter worth approximately $28,000. 1248 Management LLC bought a new position in Cigna Group in the 1st quarter worth approximately $29,000. Solstein Capital LLC acquired a new stake in Cigna Group in the 2nd quarter valued at approximately $29,000. Finally, Activest Wealth Management increased its position in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 72 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.70% of the company’s stock.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

Cigna Group Company Profile

(Get Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.